Training and Development
71 results
Applied filters
Five moments to tackle problematic polypharmacy podcasts
10 December 2025In these podcasts we discuss 5 moments to tackle problematic polypharmacy, using examples from community pharmacy practice and expert advice.
Complementary products: resources to support answering questions
21 May 2026Resources for reviewing interactions with supplements and complementary, herbal and alternative products, including homeopathy, Chinese and Ayurvedic.
Managing complementary products and conventional medicines
13 January 2026Considerations when managing interactions with supplements and complementary, herbal and alternative products, including homeopathy, Chinese and Ayurvedic.
Advising on complementary products and conventional medicines
1 December 2025Decision making when advising on interactions with supplements and complementary, herbal and alternative products, including homeopathy, Chinese and Ayurvedic.
Polypharmacy and structured medication review explainer videos
5 February 2026These animated videos explain the 7 steps of structured medication review, using a person-centred approach to managing polypharmacy
Navigating medicine supply issues in secondary care
27 November 2025Explore causes, national processes, and local strategies for effectively managing medicine supply issues in secondary care.
Inducting pharmacy procurement staff
21 November 2025Complete our induction document to support all levels of new staff working within NHS hospital pharmacy procurement teams.
Understanding the new pharmacy procurement induction programme
8 October 2025Launch of the SPS pharmacy procurement induction programme, its purpose, use, and a demonstration. For procurement staff and education & senior pharmacy leads.
Understanding biological and biosimilar medicines
1 August 2025Biosimilar medicines are a type of biological medicine that offer the NHS opportunities to deliver better value for certain conditions
The risks and principles of prescribing in pregnancy
15 July 2025Prescribing in pregnancy requires balancing maternal and fetal risks. This guidance outlines key risks and principles to ensure safe, informed decisions.